Clicky

Baxter International Inc.(BAX)

Description: Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.


Keywords: Medicine S&P 500 Infectious Diseases Disorders Nutrition Products Dialysis Kidney Disease Membrane Technology Hemodialysis Syringe Burns Medical Research Kidney Medical Products Hemophilia Nephrology Renal Disease Renal Dialysis Compounding Immune Disorders Antitrypsin Deficiency End Stage Renal Disease Hemophilia A Infusion Pump Kidney Failure Stage Renal Disease Specialty Pharmacy Alpha 1 Antitrypsin Peritoneal Dialysis Drug Wholesalers Kidney Dialysis Biosurgery Products Packaging Technologies

Home Page: www.baxter.com

BAX Technical Analysis

One Baxter Parkway
Deerfield, IL 60015
United States
Phone: 224 948 2000


Officers

Name Title
Mr. Jose E. Almeida Chairman, Pres & CEO
Mr. James K. Saccaro Exec. VP & CFO
Mr. Giuseppe Accogli Exec. VP & COO
Mr. Andrew Frye Pres of Patient Support Systems, Global Surgical Solutions & Enterprise Connectivity
Mr. Cristiano Franzi Sr. VP & Pres for EMEA
Mr. Brian C. Stevens Sr. VP, Chief Accounting Officer & Controller
Mr. Talvis P. Love Sr. VP & Chief Information Officer
Ms. Clare Trachtman VP of Investor Relations
Mr. David S. Rosenbloom Sr. VP & Gen. Counsel
Ms. Stacey Eisen Sr. VP of Global Communications

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 14.2653
Trailing PE: 22.35
Price-to-Book MRQ: 4.7926
Price-to-Sales TTM: 1.736
IPO Date: 1981-10-27
Fiscal Year End: December
Full Time Employees: 60000
Back to stocks